RxDoctor Payments DataLook up a doctor →

Cornelius Robens, MD

Neurology · Traverse City, MINPI 1538158688

Payments from drug & device makers

$202,610in general payments, 2019–2025

Across 582 payments — averaging $348.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$74K
  • AbbVie$50K
  • Biogen$23K
  • EMD Serono, Inc.$18K
  • Sanofi$14K
  • Kyowa Kirin, Inc.$8K
  • plus $15K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.90$73,750
AbbVie(2 entities)179$50,038
Biogen56$22,602
EMD Serono, Inc.65$18,407
Sanofi26$14,423
Kyowa Kirin, Inc.19$7,906
Lundbeck LLC9$5,060
Acorda Therapeutics, Inc15$4,154
Boston Scientific12$1,570
Argenx US, Inc.2$1,425
Acadia Pharmaceuticals Inc12$1,144
UCB, Inc.16$256
Lilly USA, LLC9$232
E.r. Squibb & Sons, L.L.C.2$143
Abbott4$125
Catalyst Pharmaceuticals, Inc.5$113
Bristol Myers Squibb6$113
Eisai Inc.4$111
Novartis4$78
Pfizer4$74
Merz Pharmaceuticals, LLC3$74
Ipsen Biopharmaceuticals, Inc4$69
Supernus Pharmaceuticals, Inc.4$67
Amgen5$65
MDD US Operations, LLC2$62
Johnson & Johnson(2 entities)2$59
Neurelis, Inc.3$53
Aucta Pharmaceuticals, Inc.2$51
Livanova USA, Inc.1$40
Grifols USA, LLC1$40
CSL Behring2$37
Neurocrine Biosciences, Inc.2$36
GE HealthCare1$33
Otsuka America Pharmaceutical, Inc.2$32
AstraZeneca1$23
Vanda Pharmaceuticals Inc.1$22
Revance Therapeutics, Inc.1$22
Tanabe Pharma America, Inc.1$21
Amneal Pharmaceuticals LLC1$21
Adamas Pharmaceuticals, Inc.1$17
SK Life Science, Inc.1$17
Avanir Pharmaceuticals, Inc.1$15
Sunovion Pharmaceuticals Inc.1$11

How this compares

$202,610 in reported general payments places this provider in the 90th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan →

Medicare billing

Part B allowed, 2024
$183,875
Medicare patients
333
Services billed
15,398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Traverse City

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →